Abstract
Objective COVID-19 has emerged as a global pandemic, affecting nearly 80 million people from 218 countries as of December 2020. At the same time, vitamin D deficiency seems to be prevalent among COVID-19 patients. Hence, the association between the prevalence of vitamin D deficiency and COVID-19 infection and mortality among European countries was examined.
Design A case series and recent literature review study
Settings Information on prevalence of vitamin D deficiency in each country was retrieved through literature searching on PubMed® database. As of December, 23rd 2020, COVID-19 infections and mortalities per million population were extracted from the Worldometer website, whereas the latitude of each country was taken from the CSGNetwork website. The association between both vitamin D deficiency and COVID-19 infection and mortality were explored using correlation coefficients and scatterplots.
Participants European Countries-Populations
Results The range of prevalence of vitamin D deficiency among European countries was 6.9-75.1%, with most countries facing more than 50% of vitamin D deficiency among their population. Significant positive correlations were observed between COVID-19 infections (r=0.82; p<0.001) and mortalities (r=0.53; p=0.05) per million population with the prevalence of vitamin D deficiency. Most of the high latitude countries showed lower rates of COVID-19 infections and mortalities compared to middle latitude countries.
Conclusion Prevalence of vitamin D deficiency was significantly associated with both infection and mortality rate of COVID-19 among European countries. Thus, it is an important parameter to be considered when implementing preventive measures to mitigate the mortality rate of COVID-19.
- Vitamin D
- deficiency
- COVID-19
- infections
- mortalities
- Europe
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research received no specific grant from any funding agency, commercial or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
COVID-19 infections and mortalities per million population were extracted from the Worldometer website, whereas the latitude of each country was taken from the CSGNetwork website
Abbreviations
- 1M
- One million
- 25(OH)D
- 25-hydroxyvitamin D3
- ACE2
- Angiotensin-Converting Enzyme 2
- Ang (1-7)
- Angiotensin (1-7)
- ARS
- Acute Respiratory Syndrome
- COVID-19
- Coronavirus disease 2019
- ECTS
- European Calcified Tissue Society
- ICU
- Intensive Care Unit
- ISO
- International Organization for Standardization
- MasR
- Mas Receptor
- PCR
- Polymerase Chain Reaction
- RAS
- Renin - Angiotensin System
- RICU
- Respiratory Intermediate Care Unit
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus
- UV
- Ultraviolet
- UVB
- Ultraviolet B
- Vit D
- Vitamin D
